FDIVX
Price
$51.85
Change
-$0.12 (-0.23%)
Updated
Oct 17 closing price
Net Assets
13.12B
RERCX
Price
$63.17
Change
-$0.27 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.06B
Interact to see
Advertisement

FDIVX vs RERCX

Header iconFDIVX vs RERCX Comparison
Open Charts FDIVX vs RERCXBanner chart's image
Fidelity Diversified International
Price$51.85
Change-$0.12 (-0.23%)
VolumeN/A
Net Assets13.12B
American Funds EUPAC R3
Price$63.17
Change-$0.27 (-0.43%)
VolumeN/A
Net Assets137.06B
FDIVX vs RERCX Comparison Chart in %
View a ticker or compare two or three
VS
FDIVX vs. RERCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDIVX is a Hold and RERCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 137B vs. FDIVX (13.1B). FDIVX pays higher dividends than RERCX: FDIVX (1.65) vs RERCX (0.47). FDIVX was incepted earlier than RERCX: FDIVX (34 years) vs RERCX (23 years). RERCX (1.12) is less costly to investors than FDIVX (0.59). FDIVX (35.00) and RERCX (35.00) have comparable annual turnover. FDIVX has a lower initial minimum investment than RERCX: FDIVX (0) vs RERCX (250). FDIVX annual gain was more profitable for investors over the last year : 13.67 vs. RERCX (10.58). FDIVX return over 5 years is better than : 24.22 vs. RERCX (12.22).
FDIVXRERCXFDIVX / RERCX
Total Expense Ratio0.591.1253%
Annual Report Gross Expense Ratio0.591.1253%
Fund Existence34 years23 years-
Gain YTD22.98421.108109%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets13.1B137B10%
Annual Yield % from dividends1.650.47350%
Returns for 1 year13.6710.58129%
Returns for 3 years63.3247.47133%
Returns for 5 years24.2212.22198%
Returns for 10 years52.7339.90132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.20N/A
+2.51%
Adaptimmune Therapeutics plc
HALO67.030.15
+0.22%
Halozyme Therapeutics
FCNCP22.25-0.09
-0.40%
First Citizens BancShares
RZLV4.87-0.17
-3.37%
Rezolve AI PLC
RXT1.42-0.05
-3.40%
Rackspace Technology